COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

IVERMECTIN and Multiple Sclerosis - Anti-inflammatory action, neuroprotection and re-myelination

William Makis's avatar
William Makis
Jul 06, 2024
∙ Paid

Research:

  • 2018 (Zabala et al) - P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis (Spain)

  • 2023 (Noori et al) - Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1/NF-kB/GFAP signaling pathway

User's avatar

Continue reading this post for free, courtesy of William Makis.

Or purchase a paid subscription.
© 2026 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture